← Browse by Condition
Medical Condition
relapsed diffuse large b cell lymphoma
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2
NCT06458439 Phase 2
Recruiting
Epcoritamab-CAR T Cells for Large B-cell Lymphomas
Enrollment
31 pts
Location
United States
Sponsor
Abramson Cancer Center at Penn...
NCT04920617 Phase 2
Recruiting
DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Enrollment
102 pts
Location
United States, Austr...
Sponsor
ImmunoVaccine Technologies, In...